MYCOMETER, INC.
TAMPA, FLORIDA

Mycometer, Inc., part of Mycometer A/S, started its journey in Tampa, Florida, back in 2009. Born from the innovative minds of Dr. Morten Reeslev and Dr. Morten Miller as a spin-off from their work at the University of Copenhagen's research group in 1998, the company has quickly risen to prominence on the global stage for its groundbreaking methods in detecting mold and bacteria indoors. Mycometer’s growth is marked by strategic moves like opening a sales office in Singapore in 2015, aiming to broaden its footprint in Asia. These rapid detection methods are game-changers in various industries needing prompt results, particularly those adhering to standards such as ISO 22000/HACCP for water hygiene. The success of Mycometer stems from the innovative technology that powers their products, which is well-documented and celebrated across scientific communities globally. Their systems produce quantifiable data on bacteria and fungi within an hour, offering a stark contrast to the lengthy processes traditional methods require. Such impressive capabilities are further validated by rigorous analyses conducted in partnership with the US-EPA, emphasizing robustness and reproducibility. A noteworthy aspect of their offering is the comprehensive support provided, including a mandatory proficiency course for users, ensuring consistent high standards of operation. The global trust in Mycometer’s technologies is evident through its adoption on five continents and endorsement as a preferred method by the U.S. Department of Defense since 2010. The company's portfolio features an array of patents and trademarks that highlight its solid standing in the microbiology sector, officially recognized under Florida’s DOS with the identifier P07000053367. From its headquarters at 2209 E. 5th Ave., Tampa, FL, Mycometer continues to be instrumental in transforming rapid microbial testing methods for a safer, healthier world.